|
Workshops on Viral Pathogenesis and Oncogenesis
|
5R13CA095919-08
|
$14,000
|
$700
|
FAN, HUNG
|
UNIVERSITY OF CALIFORNIA IRVINE
|
|
Vitamin D, alcohol, and risk of lymphomas in a prospective cohort of women
|
1R03CA135687-01A1
|
$72,500
|
$21,750
|
Chang, Ellen
|
NORTHERN CALIFORNIA CANCER CENTER
|
|
Veterans Administration hospitalization database, Patient Treatment File, and Out
|
ZIA CP010183-00580
|
$94,490
|
$4,724
|
McGlynn
|
DCEG (NCI)
|
|
UT M.D. Anderson Cancer Center Lymphoma SPORE
|
1P50CA136411-01A1
|
$500,000
|
$115,000
|
YOUNES, ANAS
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Understanding T Cell Rapamycin Resistance
|
ZIA BC 011220
|
$240,008
|
$24,001
|
Fowler, Daniel
|
CCR (NCI)
|
|
Tumor-Infiltrating Donor Derived Lymphocyte Therapy After Allogeneic Transplant
|
ZIC BC 011029
|
$141,032
|
$56,413
|
Hakim, Frances
|
CCR (NCI)
|
|
Towards a Mouse Model of Classical Hodgkin's Disease and PTLD
|
2R01CA098285-06A1
|
$487,828
|
$487,828
|
RAJEWSKY, KLAUS
|
IMMUNE DISEASE INSTITUTE, INC.
|
|
The Role of Fbxw7 in genetic instability and cancer
|
5R01CA116481-03
|
$355,982
|
$71,196
|
Mao, Jian-Hua
|
UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-16S1
|
$73,969
|
$740
|
Rosen, Steven
|
NORTHWESTERN UNIVERSITY
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-16S2
|
$99,471
|
$995
|
Rosen, Steven
|
NORTHWESTERN UNIVERSITY
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-16S3
|
$83,979
|
$840
|
Rosen, Steven
|
NORTHWESTERN UNIVERSITY
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
5P30CA060553-16
|
$5,084,061
|
$50,841
|
Rosen, Steven
|
NORTHWESTERN UNIVERSITY
|
|
The Mechanism of Thymic Lymphomagenesis in Genetically Engineered Mouse Model
|
ZIA BC 011192
|
$474,984
|
$237,492
|
Van Dyke, Terry
|
CCR (NCI)
|
|
The cell biology of the calcium release-activated calcium channel in T cells
|
ZIA BC 010895
|
$58,315
|
$29,157
|
Samelson, Lawrence
|
CCR (NCI)
|
|
Symptom Cluster Subgroups in Adult Survivors of Childhood Cancers
|
1R01CA136912-01A2
|
$239,033
|
$23,903
|
Finnegan, Lorna
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
Sweden and Denmark linked registries on hospital discharges and subsequent cancer
|
ZIA CP010183-00560
|
$477
|
$24
|
Gridley
|
DCEG (NCI)
|
|
Support for Human Specimen Banking in NCI-Supported Cancer Clinical Trials
|
5U24CA114766-05
|
$1,195,618
|
$119,562
|
REAMAN, GREGORY
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Study of the Roles of SDF1 and CXCR4 in Hematopoiesis
|
ZIA BC 010782
|
$327,420
|
$81,855
|
Tosato, Giovanna
|
CCR (NCI)
|
|
Study of Structures of CCR5 and Its Interactions with CCR5 Inhibitors
|
ZIA BC 011109
|
$340,900
|
$68,180
|
Mitsuya, Hiroaki
|
CCR (NCI)
|
|
Study of HIV Protease Dimerization (PD) and Identification of PD Inhibitors
|
ZIA BC 011105
|
$170,450
|
$1,705
|
Mitsuya, Hiroaki
|
CCR (NCI)
|
|
Studies of Medical Radiation and Other Therapeutic Agents
|
ZIA CP010131-04020
|
$2,310
|
$231
|
Berrington, Amy
|
DCEG (NCI)
|
|
Studies of Medical Radiation and Other Therapeutic Agents
|
ZIA CP010131-04021
|
$64,057
|
$3,843
|
Berrington, Amy
|
DCEG (NCI)
|
|
Studies of Medical Radiation and Other Therapeutic Agents
|
ZIA CP010131-04033
|
$172,949
|
$17,295
|
Berrington, Amy
|
DCEG (NCI)
|
|
Studies of Epstein-Barr Virus
|
5R37CA012055-37
|
$453,975
|
$113,494
|
MILLER, I.
|
YALE UNIVERSITY
|
|
Studies of Atomic Bomb Survivors
|
ZIA CP010134-04016
|
$480,282
|
$24,014
|
Mabuchi, Kiyohitko
|
DCEG (NCI)
|
|
Stanford University Cancer Center
|
3P30CA124435-03S1
|
$126,467
|
$1,265
|
MITCHELL, BEVERLY
|
STANFORD UNIVERSITY
|
|
Stanford University Cancer Center
|
5P30CA124435-03
|
$1,611,344
|
$16,113
|
MITCHELL, BEVERLY
|
STANFORD UNIVERSITY
|
|
St. Vincent Hospital Regional Cancer Center CCOP
|
5U10CA095968-08
|
$688,991
|
$13,780
|
SAPHNER, THOMAS
|
ST. VINCENT HOSPITAL
|
|
SPORE in Lymphoma
|
3P50CA126752-03S1
|
$371,941
|
$111,582
|
Heslop, Helen
|
BAYLOR COLLEGE OF MEDICINE
|
|
SPORE in Lymphoma
|
5P50CA126752-03
|
$2,266,618
|
$679,985
|
Heslop, Helen
|
BAYLOR COLLEGE OF MEDICINE
|
|
SPORE in Lymphoma
|
3P50CA096888-05S2
|
$304,005
|
$152,003
|
AMBINDER, RICHARD
|
JOHNS HOPKINS UNIVERSITY
|
|
South Texas Pediatric Minority Based CCOP
|
2U10CA052771-19
|
$366,615
|
$29,329
|
LANGEVIN, ANNE-MARIE
|
UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT
|
|
South Texas Pediatric Minority Based CCOP
|
3U10CA052771-19S1
|
$99,996
|
$8,000
|
LANGEVIN, ANNE-MARIE
|
UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT
|
|
Significance and Function of HGAL in Lymphoma
|
2R01CA109335-04A1
|
$263,946
|
$131,973
|
LOSSOS, IZIDORE
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
Signal transduction inhibitor therapy for Lymphoma
|
5R01CA127433-03
|
$336,563
|
$168,282
|
Witzig, Thomas
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
|
Research Management and Support
|
RMS2009 [E]
|
$350,982,837
|
$35,000
|
N/A
|
National Cancer Institute
|
|
Relapse after Allogeneci Hematopoietic Stem Cell Transplantation
|
ZIA BC 011239
|
$167,837
|
$33,567
|
Bishop, Michael
|
CCR (NCI)
|
|
Regulation of RANTES expression in T lymphocytes
|
ZIA BC 011025
|
$666,916
|
$133,383
|
Krensky, Alan
|
CCR (NCI)
|
|
Regulation of Exocytosis from Immune Cells
|
ZIA BC 011035
|
$280,523
|
$70,131
|
Roche, Paul
|
CCR (NCI)
|
|
Regulation of Epstein-Barr Virus Latency
|
5R01CA093606-07
|
$294,088
|
$235,270
|
LIEBERMAN, PAUL
|
WISTAR INSTITUTE
|
|
Registry linkage projects [including Scandinavia, SEER Medicare, other]
|
ZIA CP010176-10359
|
$323,104
|
$64,621
|
Engels
|
DCEG (NCI)
|
|
Receptor-directed Therapy
|
ZIA BC 010603
|
$924,184
|
$277,255
|
Janik, John
|
CCR (NCI)
|
|
Radiologial Physics Center
|
5U10CA010953-41
|
$2,487,286
|
$74,619
|
IBBOTT, GEOFFREY
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Quality Assurance Review Center
|
5U10CA029511-30
|
$1,737,151
|
$52,115
|
FITZGERALD, THOMAS
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
Prediction of Second Cancer Risks for Children Treated with Proton - vs. - Photon
|
5R01CA131463-02
|
$255,640
|
$89,474
|
Newhauser, Wayne
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Post-Transcriptional Regulation of Interleukin-7 Receptor Expression
|
ZIA BC 011214
|
$412,088
|
$41,209
|
Park, Jung-Hyun
|
CCR (NCI)
|
|
Phase I/II study of BCL-family inhibitors in lymphoma
|
ZIA BC 010716
|
$176,332
|
$52,900
|
Wilson, Wyndham
|
CCR (NCI)
|
|
Phase I Trials of Anti-Cancer Agents
|
5U01CA076576-12
|
$747,189
|
$127,022
|
GREVER, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Pediatric Oncology Branch Clinical Care and Education
|
ZIE BC 010764
|
$2,324,038
|
$116,202
|
Wayne, Alan
|
CCR (NCI)
|
|
Pediatric Hematology and Oncology Research
|
5T32CA009640-20
|
$239,235
|
$23,924
|
BUCHANAN, GEORGE
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
Total relevant funding to Hodgkins disease for this search: $18,224,261
|